Analysts Issue Forecasts for RARE FY2025 Earnings

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) – William Blair issued their FY2025 earnings estimates for shares of Ultragenyx Pharmaceutical in a note issued to investors on Wednesday, May 28th. William Blair analyst S. Corwin anticipates that the biopharmaceutical company will post earnings per share of ($3.48) for the year. William Blair has a “Outperform” […]

Leave a Reply

Your email address will not be published.

Previous post National Bank Financial Forecasts IAMGOLD FY2025 Earnings
Next post Equities Analysts Set Expectations for GT Q3 Earnings